Today, Merck KGaA, Darmstadt, Germany, whose U.S. healthcare arm is EMD Serono, announced that the first trial participant ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...
People living with lupus develop strengths that are unique to this journey, and it’s time we paused to honor and celebrate the strengths of a lupus warrior.
In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...
The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...
If you have a parent, sibling, or child diagnosed with lupus — but you do not have lupus yourself — you may be eligible to participate in CARE Lupus. Lupus has long been treated after symptoms begin - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results